Unknown

Dataset Information

0

Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.


ABSTRACT: We investigated N-glycan processing of immunoglobulin G1 using the monoclonal antibody cetuximab (CxMab), which has a glycosite in the Fab domain in addition to the conserved Fc glycosylation, as a reporter. Three GlcNAc (Gn) terminating bi-antennary glycoforms of CxMab differing in core fucosylation (?1,3- and ?1,6-linkage) were generated in a plant-based expression platform. These GnGn, GnGnF(3), and GnGnF(6) CxMab variants were subjected in vivo to further processing toward sialylation and GlcNAc diversification (bisected and branching structures). Mass spectrometry-based glycan analyses revealed efficient processing of Fab glycans toward envisaged structures. By contrast, Fc glycan processing largely depend on the presence of core fucose. A particularly strong support of glycan processing in the presence of plant-specific core ?1,3-fucose was observed. Consistently, molecular modeling suggests changes in the interactions of the Fc carbohydrate chain depending on the presence of core fucose, possibly changing the accessibility. Here, we provide data that reveal molecular mechanisms of glycan processing of IgG antibodies, which may have implications for the generation of glycan-engineered therapeutic antibodies with improved efficacies.

SUBMITTER: Castilho A 

PROVIDER: S-EPMC4622071 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.

Castilho Alexandra A   Gruber Clemens C   Thader Andreas A   Oostenbrink Chris C   Pechlaner Maria M   Steinkellner Herta H   Altmann Friedrich F  

mAbs 20150101 5


We investigated N-glycan processing of immunoglobulin G1 using the monoclonal antibody cetuximab (CxMab), which has a glycosite in the Fab domain in addition to the conserved Fc glycosylation, as a reporter. Three GlcNAc (Gn) terminating bi-antennary glycoforms of CxMab differing in core fucosylation (α1,3- and α1,6-linkage) were generated in a plant-based expression platform. These GnGn, GnGnF(3), and GnGnF(6) CxMab variants were subjected in vivo to further processing toward sialylation and Gl  ...[more]

Similar Datasets

| S-EPMC11345378 | biostudies-literature
| S-EPMC2761508 | biostudies-literature
| S-EPMC5653758 | biostudies-literature
| S-EPMC9982779 | biostudies-literature
| S-EPMC5131652 | biostudies-literature
| S-EPMC7531492 | biostudies-literature
| S-EPMC8990897 | biostudies-literature
| S-EPMC9161449 | biostudies-literature
| S-EPMC9761184 | biostudies-literature
| S-EPMC4245247 | biostudies-literature